DA TONG SHI SHI EN TE FU SHI YOU XIAN GONG SI – Trademark Portfolio

Entity Type: 99

DA TONG SHI SHI EN TE FU SHI YOU XIAN GONG SI holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 1 filings in this category. Currently, 1 trademark is registered. Notable registered marks include VANSPHERE. The owner is based in DA TONG SHAN XI.

SHAN XI SHENG DA TONG SHI

DA TONG SHAN XI 037000 , CN

1 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

VANSPHERE
VANSPHERE
Registered 2023

Trademark Classifications

DA TONG SHI SHI EN TE FU SHI YOU XIAN GONG SI's trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

10
Medical Apparatus (1 filing)

Surgical, medical, dental and veterinary apparatus and instruments

Frequently Asked Questions

How many trademarks does DA TONG SHI SHI EN TE FU SHI YOU XIAN GONG SI have?

DA TONG SHI SHI EN TE FU SHI YOU XIAN GONG SI has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.

What trademark classes does DA TONG SHI SHI EN TE FU SHI YOU XIAN GONG SI file in?

DA TONG SHI SHI EN TE FU SHI YOU XIAN GONG SI files trademarks across 1 Nice Classification class. The most active classes are Class 10 (Medical Apparatus). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.

What are DA TONG SHI SHI EN TE FU SHI YOU XIAN GONG SI's most well-known trademarks?

DA TONG SHI SHI EN TE FU SHI YOU XIAN GONG SI's registered trademark portfolio includes well-known marks such as VANSPHERE. These are among 1 currently registered trademark in the portfolio.

What is DA TONG SHI SHI EN TE FU SHI YOU XIAN GONG SI's trademark registration success rate?

DA TONG SHI SHI EN TE FU SHI YOU XIAN GONG SI has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.